Abstract:OBJECTIVE:Glycogen debranching enzyme (AGL) plays an important role in complete degradation of the glycogen, and has two independent catalytic activities, i.e., those of alpha-1, 4-glucanotransferase (EC 2.4. 1.25) and amylo-1,6-glucosidase (EC 3.2. 1.33). A deficiency in activities of AGL causes excessive accumulation of glycogen with short branched outer chains and results in glycogen storage disease type III (GSD III; MIM #232 400), an autosomal recessive inborn disorder of glycogen metabolism. The present study aimed to investigate the mutation of AGL in 10 Chinese patients with GSD III.METHOD:Clinical and laboratory data of 10 patients with typical clinical manifestations of GSD III suggesting hypoglycemia, hyperlipidemia, increased creatine-phosphokinase and its isozyme were collected. The coding regions and their flanking introns of AGL gene of the 10 patients were amplified by PCR and analyzed by direct DNA sequencing. All the mutated alleles were confirmed by bidirectional DNA sequencing. The 3 novel splicing mutations were analyzed by restriction fragment length polymorphism (RFLP) in 50 healthy children (control). The 2 small deletions (c.408-411delTTTG, c.2717-2721delAGATC) were analyzed by fluorescent polymerase chain reaction and gene scan analysis to confirm the number of deleted bases.RESULT:Thirteen different mutations were identified, including 4 splicing mutations (IVS6 + 1G > A, IVS6-1G > A, IVS14 + 1G > T, IVS26-2A > C), 5 nonsense mutations (R469X, R864X, S929X, R977X, Y1428X), 3 small deletions (c.408-411delTTTG, c.2717-2721delAGATC, c.2823delT) and 1 insert mutation (c.4234insT). Except for IVS14 + 1G > T, R864X, and R977X, the other 10 mutations are novel; 18 mutated alleles were identified in the 20 alleles (90%). IVS14 + 1G > T was the most frequently seen mutation, accounting for 5 of 20 (25%) alleles examined. None of homozygote and heterozygote of the 3 novel splicing mutations was found in the 50 healthy controls by RFLP analysis. With the fluorescent polymerase chain reaction and gene scan analysis, c.408411deTTTG mutation and c.2717-2721delAGATC mutation were confirmed to have 4 and 5 bases deletion respectively.CONCLUSION:Thirteen mutations were identified in the 10 cases with GSD III, with 10 novel mutations. IVS14 + 1G > T was a relatively common mutation. This study revealed the heterozygosity of AGL gene in Chinese patients with GSD III.

The Novel Compound Heterozygous Mutations in the AGL Gene in a Chinese Family With Adult Late-Onset Glycogen Storage Disease Type IIIa

Genetic Analysis and Clinical Assessment of Four Patients with Glycogen Storage Disease Type IIIa in China

[Clinical and Gene Mutation Analysis of Three Children with Late-Onset Glycogen Storage Disease Type Ⅱ with Hypertrophic Cardiomyopathy].

Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III

Molecular Genetic Analysis of 10 Chinese Patients with Glycogen Storage Disease Type Iii

The biallelic novel pathogenic variants in AGL gene in a chinese patient with glycogen storage disease type III

[Identification of a Novel Mutation of AGL Gene in Two Siblings Affected with Glycogen Storage Disease Type IIIa].

[Analysis of Clinical Features and AGL Gene Mutations in a Family with Glycogen Storage Disease Type IIIa].

[AGL gene analysis of a pedigree with glycogen storage disease type III and identification of a novel mutation]

[Clinical Features and Acid Alpha-Glucosidase Gene Mutation in 7 Chinese Patients with Glycogen Storage Disease Type II].

Molecular Characterization of Glycogen Storage Disease Type III

Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa

A Novel Nonsense Mutation P.w738x of GAA Gene Identified in a Chinese Patient with Infantile Glycogen Storage Disease Type II

Mutation Analysis of AGL Gene in 7 Chinese Patients with Glycogen Storage Disease Type Ⅲ

A Novel Compound Heterozygous Variant of the SLC12A3 Gene in Gitelman Syndrome Pedigree

Spectrum of amyloglucosidase mutations in Asian Indian patients with Glycogen storage disease type III

[Clinical characteristics and GAA gene mutation in children with glycogen storage disease type II: an analysis of 3 cases].

Clinical and genomic study of the infant with glycogen storage disease typeⅡ

Clinical and Pathological Features of Late-onset Glycogen Storage Disease Type Ⅱ

The 81st case:a 58 years old male patient presented with later motor milestone, frequent falling for 55 years, weakness of lower limbs for 13 years, upper limbs weakness for 3 years

Glycogen storage disease typeⅠa:a pedigree study